Last: | $0.8225 |
---|---|
Change Percent: | 1.4% |
Open: | $0.811 |
Close: | $0.8225 |
High: | $0.84 |
Low: | $0.7753 |
Volume: | 44,894 |
Last Trade Date Time: | 04/28/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.8225 | $0.811 | $0.8225 | $0.84 | $0.7753 | 44,894 | 04-28-2023 |
$0.844 | $0.78 | $0.844 | $0.8503 | $0.7346 | 192,219 | 04-27-2023 |
$0.7701 | $0.7512 | $0.7701 | $0.795 | $0.75 | 158,310 | 04-26-2023 |
$0.81 | $0.9723 | $0.81 | $1 | $0.77 | 2,116,565 | 04-25-2023 |
$0.91 | $0.76 | $0.91 | $0.93 | $0.76 | 517,316 | 04-24-2023 |
$0.76 | $0.68 | $0.76 | $0.77 | $0.662 | 164,981 | 04-21-2023 |
$0.67 | $0.6999 | $0.67 | $0.6999 | $0.6454 | 135,488 | 04-20-2023 |
$0.6699 | $0.66 | $0.6699 | $0.6699 | $0.6 | 72,229 | 04-19-2023 |
$0.6399 | $0.6112 | $0.6399 | $0.66 | $0.6112 | 113,185 | 04-18-2023 |
$0.63 | $0.56 | $0.63 | $0.7099 | $0.55 | 543,616 | 04-17-2023 |
$0.55 | $0.53 | $0.55 | $0.555 | $0.52 | 22,762 | 04-14-2023 |
$0.5325 | $0.52 | $0.5325 | $0.5488 | $0.512201 | 51,860 | 04-13-2023 |
$0.512 | $0.527 | $0.512 | $0.5299 | $0.509 | 35,039 | 04-12-2023 |
$0.53 | $0.5 | $0.53 | $0.5399 | $0.5 | 37,023 | 04-11-2023 |
$0.5345 | $0.53 | $0.5345 | $0.5399 | $0.52 | 56,337 | 04-10-2023 |
$0.5156 | $0.5177 | $0.5156 | $0.5489 | $0.5156 | 27,539 | 04-07-2023 |
$0.5156 | $0.5177 | $0.5156 | $0.5489 | $0.5156 | 27,539 | 04-06-2023 |
$0.542 | $0.52 | $0.542 | $0.5489 | $0.52 | 47,856 | 04-05-2023 |
$0.5247 | $0.5489 | $0.5247 | $0.5489 | $0.52 | 43,193 | 04-04-2023 |
$0.54 | $0.5469 | $0.54 | $0.559 | $0.5142 | 25,799 | 04-03-2023 |
News, Short Squeeze, Breakout and More Instantly...
GAAP Net Income of $8.3 million or $0.25 per diluted share Non-GAAP Net Income of $11.0 million or $0.33 per diluted share Declares Third Consecutive Quarterly Dividend Immersion Corporation (NASDAQ: IMMR), a leading developer and provider of technologies for haptics, to...
IMV Inc. (the “ Company ” or “ IMV ”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX ® platform to treat solid and hematologic cancers, today announced tha...
Horizon Technology Finance Announces First Quarter 2023 Financial Results PR Newswire - First Quarter 2023 Net Investment Income per Share of $0.46 ; NAV per Share of $11.34 - - Debt Portfolio Yield of 16.3% - - Grew Portfolio Year over Year by 39% to ...